Brief: Neoleukin Therapeutics Announces 1-For-5 Reverse Stock Split
Sept 22 (Reuters) - Neoleukin Therapeutics Inc NLTX.O :
* NEOLEUKIN THERAPEUTICS ANNOUNCES 1-FOR-5 REVERSE STOCK
SPLIT
* NEOLEUKIN THERAPEUTICS INC - REVERSE STOCK SPLIT WILL
BECOME
EFFECTIVE AT 12:01 A.M. EASTERN TIME ON SEPTEMBER 25, 2023
Source text for Eikon: ID:nGNXb1d70s
Further company coverage: NLTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurogene
See all newsBrief: Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Neurogene Inc reports results for the quarter ended June 30 - Earnings Summary
Neurogene Q2 adjusted loss per share misses estimates on employee costs
Neurogene Inc expected to post a loss of $1.42 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Kroger, Meta, Sable